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We genotyped three polymorphisms of the promoter region of the interleukin-10 (IL-10) gene in 220 CF patients from the CF Center of Bari,
and tested for an association between genetic variants of the cytokine and chronic airway colonization with Pseudomonas aeruginosa. We found
that carriers of the high-IL-10-producing-GCC haplotype had significantly higher risk of chronic pulmonary infection with the pathogen.
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Chronic infection with Pseudomonas aeruginosa (P. aerugi-
nosa) represents a major cause of lung disease in cystic fibrosis
(CF) [1]. The observation that the severity of pulmonary disease
usually does not correlate with the CFTR genotype, has raised
the hypothesis that other environmental and genetic factors
could affect the CF lung phenotype [2]. Several studies suggest
that IL-10 plays a pivotal role in modulating an excessive
activity in the inflammatory cascade, down-regulating the
production of some cytokines [3,4]. It has been demonstrated
that bronchoalveolar lavage fluid (BALF) from CF patients
contains high concentrations of proinflammatory cytokines,
such as TNF-α, IL-1β, IL-6, and IL-8, but negligible amounts of
IL-10, as compared to healthy volunteers [5]. Bonfield et al. [6]
have also demonstrated that bronchial epithelial cells from CF
patients produce lower amounts of IL-10 compared to control
subjects. The same authors documented that IL-10 deficiency
results in increased local and systemic morbidity in mice with
chronic endobronchial infection from P. aeruginosa [7].⁎ Corresponding author. Clinica Pediatrica “S. Maggiore”, Policlinico, Piazza
Giulio Cesare, 11-70124 Bari (Italy). Tel.: +39 080 5592844; fax: +39 080
5478911.
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doi:10.1016/j.jcf.2007.11.004Recent studies support also the concept that polymorphisms
in the promoter region of IL-10 gene could affect the
production of this cytokine in several inflammatory disorders
[8–10].
The purpose of the present study was to test the hypothesis
that a genetically determined variation in the production of IL-10
might influence the development of chronic infection with P.
aeruginosa in patients with CF.
2. Methods
2.1. Patients
Clinical charts were examined of 220 Caucasian patients
who attended a regional referral CF Center in Southern Italy
from 1996 to 2006. The diagnosis of CF was established on
the basis of the results of 2 sweat chloride tests (N60 mmol/L),
and the identification of mutations in the CFTR gene [11,12].
The CFTR genotypes were grouped in severe/severe (carriers
of classes I, II and III mutations), mild (carriers of classes IV
and V mutations) and unknown/unknown. The study protocol
was approved by the local Ethics Committee. Clinical,
biological, and functional data were obtained retrospectively
from patients' hospital records. Results of pulmonary function
tests (measurements of forced expiratory volume in 1 s, FEV1,d by Elsevier B.V. All rights reserved.
Table 1
Clinical features of the study population
Patients characteristic
Male/female ratio 1/1
Median age at diagnosis in years (range) 2.4 (1–14)
Present median age in years (range) 16 (1–46)
P. aeruginosa colonization 124/175 (71%)
Median age of colonization in years (range) 9.0 (4.5–19)
Median age of first infection in years (range) 5.8 (3.2–8)
Median FEV1 as % of predicted (range) 76 (20–126)
Severe/severe CFTR genotype a 179/220 (81%)
Mild; unknown/unknown CFTR genotype a 41/220 (19%)
Median % FEV1 (range) in severe/severe CF phenotypes 77 (20–126)
Median % FEV1 (range) in mild/unknown CF phenotypes 67 (32–112)
PS/PI ratio 0.1/1
a Severe CFTRgenotype =mutations of classes I, II, III;MildCFTRgenotype =
mutations of classes IV and V; PS/PI = Pancreatic sufficiency/insufficiency.
Table 2
General and clinical characteristics of CF patients divided into P. aeruginosa
colonized and non-colonized patients
Patients characteristic P. aeruginosa
colonized (n=124)
Non-colonized
(n=51)
Male/female ratio 1/1 0.8/1
Median age at diagnosis in years (range) 1.4 (1–9) 1.6 (1–14)
Present median age in years (range) 22 (4–46) 8 (3–27) b
Median FEV1 as % of predicted (range) 68 (20–126) 92 (62–119) c
Severe/severe CFTR genotype a 107/124 (86%) 47/51 (92%)
Mild; unknown/unknown
CFTR genotype a
17/124 (14%) 4/51 (8%)
Median % FEV1 (range) in
severe/severe CF phenotypes
74 (20–126) 94 (62–119)
Median % FEV1 (range) in
mild/unknown CF phenotypes
60 (55–67) 81 (73–89)
PS/PI ratio 0.1/1 0.2/1
a Severe CFTR genotype =mutations of classes I, II, III; Mild CFTR genotype =
mutations of classes IVand V; PS/PI = Pancreatic sufficiency/insufficiency.
b χ2 p=0.001.
c χ2 p=0.006.
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(71%) patients. Sputum swabs were collected in 175 (79%)
subjects during a routine visit (patients were regularly
examined at 4-month intervals) as well as twice during
hospitalization. Chronic P. aeruginosa infection was defined
as the presence of this pathogen in the sputum cultures in at
least three consecutive samples collected in a 6-month period
[13]. Informed consent on DNA analysis was obtained from
the participants, or in case of minors, from parents.
2.2. Molecular genetic methods
Genomic DNA was extracted from blood samples, and the
single nucleotide polymorphisms (SNPs) at position -1082 (A/G),
-819 (C/T) and -592 (C/A) in the promoter region of the IL-10
were genotyped by use of polymerase chain reaction (PCR)
and restriction fragment length polymorphism (RFLP), as
described elsewhere [10]. The alleles combination of the SNPs
gives rise to three main haplotypes in Caucasians: GCC, ACC,
ATA [9,10].
2.3. Processing of sputum samples, culture of P. aeruginosa
and phenotypic analysis
Sputum samples from all patients were mixed with equal
volumes of 1% dithiothreitol (Merck, Darmstadt, Germany)
before incubation at 37 °C for 30 min. All specimens were
examined microscopically and cultured. Isolates obtained from
the samples were identified by the Phoenix (Becton Dickinson,
Sparks, MA, USA) automated system.
2.4. Statistical analysis
Statistical analyses were performed using SPSS® for
Windows software (SPSS Inc., version 11.0, Chicago, IL).
Pearson Chi-square or Fisher Exact test were used for
categorical data. Differences between groups were tested with
the nonparametric Kruskal–Wallis test. Linear regression
analyses were calculated for determination of the influence of
confounding variables (gender, birth date, age at diagnosis ofCF, CFTR genotype, and pancreatic status) on the outcome.
Haplotypes were inferred from promoter IL-10 SNPs by
Bayesian methods as implemented in the Phase software [14].
Odds ratios (OR) with 95% confidence intervals (CI) for
infection susceptibility of specific IL-10 haplotypes were
determined using association analysis with FBAT, adjusting
for confounders [15].
3. Results
Clinical features of patients enrolled to the study are
summarized in Table 1. We found a high rate (71%) of chronic
P. aeruginosa infection in our CF population. Demographic and
clinical characteristics of chronic P. aeruginosa colonized and
non-colonized CF patients are shown in Table 2. There were
significant differences between these two groups of CF patient
in median age and median FEV1 values. CFTR mutations/CF
phenotype did not affect both the P. aeruginosa colonization
status as well as patients FEV1 values.
The frequencies of alleles, genotypes and haplotypes of
IL-10 gene are shown in Table 3. The genotype–allele
distribution for the IL-10 SNPs followed the Hardy–Weinberg
equilibrium. The -819 and the -592 SNPs were in complete
linkage disequilibrium in our population. Table 3 shows that,
although not significantly, the frequency of the -1082AA
genotype tended to be higher than the GG genotype in P.
aeruginosa non-colonized patients compared with colonized
subjects (63% vs 10% and 46% vs 17%, p=0.09). This different
genotype frequency was reflected in the haplotype distribution
in the two study groups: the ACC haplotype was observed twice
as frequent as the GCC haplotype among non-colonized
patients compared to colonized subjects (46% vs 24% and
34% vs 35%, p=0.01). Single -1082 SNP analysis also revealed
that out of 33 patients homozygous for GG, 27 (81%) were
colonized and 6 (18%) were not colonized (Table 4), while of
101 patients carrying the AA genotype at the same SNP, 67
(66%) were colonized and 34 (34%) were non-colonized
Table 4
Association between P. aeruginosa airway colonization, IL-10 genotypes and
IL-10 haplotypes
IL-10 genotypes Frequency of colonization OR (95% CI)
-1082 (A/G)
A/A 0.66 (67/101) 0.69 (0.21–2.23)
A/G 0.78 (67/86) 1.25 (0.34–4.53)
G/G 0.81 (27/33) Ref
-819 (C/T)
C/C 0.74 (85/115) 0.70 (0.17–2.83)
C/T 0.67 (56/83) 1.00 (0.13–7.39)
T/T 0.80 (18/22) Ref
-592 (C/A)
C/C 0.74 (85/115) 0.70 (0.17–2.83)
C/A 0.67 (56/83) 1.00 (0.13–7.39)
A/A 0.80 (18/22) Ref
IL-10 haplotypes
GCC 0.79 (120/151) a 2.34 (1.12–4.90) b
ATA 0.73 (91/124) 1.75 (0.86–3.56)
ACC 0.65 (108/165) Ref
OR = odds ratio; CI = confidence interval; Ref = reference genotype/haplotype
used for comparison.
a χ2 p value GCC vs ACC=0.04.
b p=0.02, analyzed by logistic regression analysis, controlling for age as
covariate.
Table 5
Frequency of CFTR genotypes distribution among IL-10 genotypes and
haplotypes
IL-10 genotypes Frequency of a
severe/severe CFTR
genotype (n=179)
Frequency of
bmild; unknown/unknown
CFTR genotype (n=41)
-1082 (A/G)
A/A 0.48 (87) 0.28 (11) c
A/G 0.34 (60) 0.60 (25)
G/G 0.18 (32) 0.12 (5)
-819 (C/T)
C/C 0.51 (91) 0.66 (27) c
C/T 0.40 (72) 0.30 (12)
T/T 0.09 (16) 0.04 (2)
-592 (C/A)
C/C 0.51 (91) 0.66 (27) c
C/A 0.40 (72) 0.30 (12)
A/A 0.09 (16) 0.04 (2)
IL-10 haplotypes
GCC 0.34 (122) 0.44 (36) d
ATA 0.37 (103) 0.17 (14)
ACC 0.29 (133) 0.39 (32)
a Severe CFTR genotype = mutations of classes I, II, III.
b Mild CFTR genotype = mutations of classes IV and V.
c χ2 p=0.001 for the three genotype combinations of each polymorphism in
the two groups.
d χ2 p value GCC vs ATA vs ACC=0.07.
Table 3
Alleles, genotypes and haplotypes frequencies in the study population divided
into P. aeruginosa colonized and non-colonized patients
IL-10 alleles
and genotypes
aFrequency in all
patients (n=220)
aFrequency in
colonized (n=124)
aFrequency in
non-colonized (n=51)
-1082 (A/G)
A 0.65 (288/440) 0.65 (160/248) 0.76 (77/102)
G 0.35 (152/440) 0.35 (88/248) 0.24 (25/102)
A/A 0.46 (101/220) 0.46 (57/124) 0.63 (32/51)
A/G 0.39 (86/220) 0.37 (46/124) 0.27 (14/51)
G/G 0.15 (33/220) 0.17 (21/124) 0.10 (5/51)
-819 (C/T)
C 0.71 (313/440) 0.68 (169/248) 0.69 (70/102)
T 0.29 (127/440) 0.32 (79/248) 0.31 (32/102)
C/C 0.52 (115/220) 0.51 (63/124) 0.47 (24/51)
C/T 0.38 (83/220) 0.34 (42/124) 0.43 (22/51)
T/T 0.10 (22/220) 0.15 (19/124) 0.10 (5/51)
-592 (C/A)
C 0.71 (313/440) 0.68 (169/248) 0.69 (70/102)
A 0.29 (127/440) 0.32 (79/248) 0.31 (32/102)
C/C 0.52 (115/220) 0.51 (63/124) 0.47 (24/51)
C/A 0.38 (83/220) 0.34 (42/124) 0.43 (22/51)
A/A 0.10 (22/220) 0.15 (19/124) 0.10 (5/51)
IL-10 haplotypes
GCC 0.34 (151/440) 0.35 (88/248) 0.24 (24/102) b
ACC 0.38 (165/440) 0.34 (83/248) 0.46 (47/102)
ATA 0.28 (124/440) 0.31 (77/248) 0.30 (31/102)
a Relative allele and haplotype frequency on the total number of chromosomes;
relative genotype frequency on the total number of patients.
b χ2 p value GCC vs ACC=0.01, comparing colonized and non-colonized
patients.
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GCC was associated with an increased risk of chronic infection
with P. aeruginosa as compared to ACC haplotype (Table 4). No
association was found between haplotypes and median FEV1
values in the total CF population [GCC 73% (range 20–126%)
vs ACC 75% (range 20–125%) vs ATA 84% (range 26–126%);
p=0.365]. Finally, the distribution of the CFTR genotypes in the
IL-10 genotypes and haplotypes is reported in Table 5. There
were significant differences in the distribution of the three
genotypes for each SNP in both groups of patients, stratified for
CFTR mutation genotype. The haplotype analysis revealed that
the distribution of the GCC, ATA and ACC haplotypes was
similar among carriers of the severe CFTR genotypes (34% vs
37% vs 29%), while, although not significantly, it was different
among carriers of the mild/unknown one (44% vs 17% vs 39%,
p=0.07).
4. Discussion
Chronic pulmonary infection and the ensuing destructive
inflammatory process is still the major cause of morbidity and
mortality in CF patients despite great progresses in antimicro-
bial therapy. In keeping with other studies [16,17], we found
that patients with P. aeruginosa chronic airway colonization
had significantly lower median FEV1 values than non-
colonized patients (Table 2). However, considering that
colonized patients showed a higher median age than non-
colonized subjects, this result may be affected by the age decline
in lung function FEV1 values in CF. Efforts have been made to
332 R. Tesse et al. / Journal of Cystic Fibrosis 7 (2008) 329–332understand how IL-10-mediated suppressor pathways may be
relevant in the regulation of the inflammatory response to
microbial agents in CF [4–7]. Some authors have shown that
airway epithelial cells from patients with CF are deficient in IL-
10 production [6]. However, Casaulta et al. [18] demonstrated
that peripheral blood mononuclear cells of CF patients secrete
more IL-10 than healthy individuals after polyclonal T-cell
stimulation. We found that the percentage of colonized patients
was higher among homozygous for GG at -1082 compared to
subjects carrying the -1082AA genotype, and that the high-IL-
10-producing haplotype GCC was associated with a greater risk
of P. aeruginosa airway colonization (Table 4). This seems to
be consistent with the results of Brouard et al. [19], who showed
a significant relationship between the -1082GG genotype and
colonization with Aspergillus fumigatus in CF patients.
Furthermore, other association studies of IL-10 gene poly-
morphisms with infectious lung diseases have shown a
correlation between the same -1082GG genotype and the
severity of community-acquired pneumonia and pneumococcal
infection in hospitalized patients [20,21]. Unexpectedly, IL-10
haplotypes did not related to median FEV1 values in our
population and there are not similar studies in literature that may
confirm our results in CF patients. We speculate that IL-10
haplotypes may influence the susceptibility to pulmonary
infection, but not lung function performances. In agreement
with our results, no association was found between IL-10 SNPs
and the rate of decline in FEV1 in chronic obstructive
pulmonary disease [22]. Contrarily, Lyon et al. [23] documented
that the GCC haplotype was positively and the ATA haplotype
negatively associated with FEV1 in asthmatic children.
However, different mechanisms of inflammation are involved
in asthma and CF lung infection. It is noteworthy that IL-10
haplotypes were affected by CFTR genotypes in our cohort
(Table 5). Although our preliminary findings warrant confirma-
tion by other groups, the data emerging from the present study
suggest that IL-10 promoter haplotypes may represent a genetic
factor, which may interact with mutations within CFTR and the
environment, in determining susceptibility to P. aeruginosa
infection and affecting prognosis in CF.
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